NowPatient Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.1/10
Best for: an oral route if you will not self-inject
NowPatient falls below our bar on disclosure. Read the breakdown below before you give it money.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked July 2026
Nothing is charged for the consultation at NowPatient; the medication is the whole bill. Because the out-of-pocket cost tracks brand list prices, an uninsured patient faces roughly $1,000-$1,350/mo. Access is to brand-name GLP-1s for weight management: Saxenda is on the menu, so is Mounjaro, and Wegovy comes as an injection and as an oral tablet. The company spans the US and UK, HQ Austin, TX.
Is NowPatient legit?
Yes. NowPatient is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 6.1/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a NowPatient promo or coupon code?
We know of no promo or coupon code for NowPatient. Its listed price is $1,069 a month. Coupon sites advertising "NowPatient discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how NowPatient compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to NowPatient
Trimi Health
Best for: knowing which pharmacy fills the vial: it names VialsRx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
NowPatient at a glance
- Type
- GLP-1 telehealth provider
- Starting price
- $1,069/mo
- What's included
- Medication · Consult
- FDA status
- No FDA warning letters found
How NowPatient scores
Six columns, each one computed from something NowPatient has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
6.1/10$1069/month is 14% below the $1249 median for brand-name tirzepatide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses liraglutide, semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
2.5/10No price appears until the medical intake is finished. A live video visit is required, which is slower but the more careful intake.
Trust & Safety15%
4.0/10No pharmacy is named for its prescriptions. Its price appears only after the medical intake.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
5.5/10The price covers the medication and clinician visits.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on NowPatient
Last checked July 2026- Checked the listed price across 4 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for NowPatient
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with NowPatient involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1NowPatient shows a price only after you finish its medical questionnaire, so you cannot compare costs until you have shared health information.
- 2The intake requires a live video visit with a clinician before a first prescription, which takes longer than a written form and is the more careful route.
- 3Ask NowPatient which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 4The monthly price includes the medication and clinician visits.
- Lowest ongoing monthly price: tirzepatide $1069, semaglutide $1349, liraglutide $1349. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that NowPatient serves your state before you start.
Contacting NowPatient
- NowPatient offers email support
- Hours
- Mon-Fri 8am-5pm EST (US); Mon-Fri 9am-6pm GMT (UK)
GLP-1 medications NowPatient offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Check the price yourself before you pay
Every figure here was read off NowPatient's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Tirzepatide costs $1069 a month, 14% below the $1249 median for brand-name tirzepatide across the sellers we compare
- The monthly price includes the medication and clinician visits
- We found no FDA warning letters issued to NowPatient
- A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
Against it
- Semaglutide costs $1349 a month, 35% above the $997 median for brand-name semaglutide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
What NowPatient charges
The standing price at NowPatient is $1,069/month. That sits at the affordable end of what we see.
- Brand-name tirzepatide: $1,069/month
- Brand-name semaglutide: $1,349/month
- Brand-name semaglutide: $1,349/month
- Brand-name liraglutide: $1,349/month
For brand-name tirzepatide, the median across the sellers we compare is $1,249/month, so NowPatient's $1,069 is genuinely below the middle, not just advertised that way.
MangoRx dispenses semaglutide and tirzepatide from $299/month, which makes it the fair comparison to run before you commit here.
What NowPatient dispenses
NowPatient prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. These are FDA-approved brand-name products rather than compounded preparations, which is the more expensive route and the one where what is in the pen has been reviewed.
Safety and disclosure
Before you start an intake, ask NowPatient which states it serves, which pharmacy fills its prescriptions and what the monthly price includes. We found no FDA warning letters issued to NowPatient. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You need insurance to cover the cost. Check whether NowPatient bills your plan before you start.
It fits if
- the lowest standing monthly cost is what you are solving for
Our read
NowPatient competes on price: $1,069/month. The catch is disclosure, which is why NowPatient scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you.
The Bottom Line
NowPatient falls below our bar on disclosure. Read the breakdown below before you give it money.
Before you pay NowPatient
Starting at $1,069 a month. Check today's price, then start the intake.
Where NowPatient is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If the standing monthly cost is what decides it, consider Sesame Care (from $59/mo).
- If you want a human checking in, not just a prescription, consider ShedRx.
Compare NowPatient head to head
The sellers closest to NowPatient on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this NowPatient review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of July 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See NowPatient's current pricing
Plans start at $1,069 a month. Whether you qualify is a clinician's decision, made after your intake.